SCHEMBL297213

SCHEMBL297213

CCN(CC)c1cc[c]c2ccccc12

nearest known ligand 0.33

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.33
SLC40A1 Q9NP59 1/20 0.33
ACP1 P24666 1/20 0.33
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
ELANE P08246 1/20 0.32
ACHE P22303 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
KDM1A O60341 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297736 0.87 AR (0.33) ARSLC40A1L3MBTL1ACHEALDH1A1
SCHEMBL298360 0.83 ELANE (0.38) TSHRELANEALDH1A1MAPTMAPK1
SCHEMBL9252140 0.80 APAF1 (0.38) TSHRL3MBTL1ALDH1A1MAPT
SCHEMBL249747 0.79 CHEK1 (0.44) TSHRL3MBTL1ALDH1A1MAPTKDM1A
SCHEMBL7029003 0.77 CCR5 (0.35) ALDH1A1MAPTMAPK1CNR2
SCHEMBL11176674 0.77 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL296148 0.76 KDM4E (0.33) L3MBTL1ALDH1A1MAPT
SCHEMBL9830323 0.74 ELANE (0.32) ELANE
SCHEMBL4014825 0.74 CRHR1 (0.37)
SCHEMBL9256410 0.73 CHKA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070020793-A1 Three-dimensional shaped solid dosimeter and method of use ADAMOVICS JOHN A 2007-01-25 US claimed
US-11015061-B2 Phthalocyanine-based compound and uses of same YAMAMOTO CHEMICALS, INC. (JP) 2021-05-25 US disclosed
US-20200032066-A1 PHTHALOCYANINE-BASED COMPOUND AND USES OF SAME YAMAMOTO CHEMICALS, INC. (JP) 2020-01-30 US disclosed
EP-1501897-B1 METHOD FOR THE PRODUCTION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIIMIDES AND PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIANHYDRIDE AND NAPHTALENE-1,8-DICARBOXYLIMIDES BASF SE (DE) 2012-03-14 EP disclosed
US-7807836-B2 Preparation of perylen-3,4:9,10-tetracarboxylic dianhydride and also of naphtalene-1,8-dicarboximides BASF AKTIENGESELLSCHAFT (DE) 2010-10-05 US disclosed
US-20080161569-A1 PREPARATION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC DIANHYDRIDE AND ALSO OF NAPHTALENE-1,8-DICARBOXIMIDES BASF AKTIENGESELLSCHAFT (DE) 2008-07-03 US disclosed
US-7393956-B2 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides BASF AKTIENGESELLSCHAFT (DE) 2008-07-01 US disclosed
US-20070020793-A1 Three-dimensional shaped solid dosimeter and method of use ADAMOVICS JOHN A 2007-01-25 US disclosed
US-20050131220-A1 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 US disclosed
US-5279655-A Triarylmethane dye or lake pigment FUJICOPIAN CO., LTD. (JP) 1994-01-18 US disclosed
EP-0502200-A1 PRINTER INK COMPOSITION AND PRINTING MEDIUM PREPARED THEREFROM FUJICOPIAN CO., LTD. (JP) 1992-09-09 EP disclosed
EP-0304613-B1 BENZOPYRAN DERIVATIVES BASF Aktiengesellschaft (DE) 1991-06-26 EP disclosed
US-4958021-A PRESSURE AND HEAT SENSITIVE RECORDING MATERIALS BASF AKTIENGESELLSCHAFT (DE) 1990-09-18 US disclosed
EP-0304613-A1 Benzopyran derivatives BASF Aktiengesellschaft (DE) 1989-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161569-A1 PREPARATION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC DIANHYDRIDE AND ALSO OF NAPHTALENE-1,8-DICARBOXIMIDES CLIC1, PNPO, CLIC4 AR 3737/4885SLC40A1 2345/4885ACP1 383/4885
US-20050131220-A1 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides CBR1, CBR3, SCO2 AR 2073/4885SLC40A1 2185/4885ACP1 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.